drugset / Trial / NCT00970593
Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a study to evaluate the safety, tolerability, and activity of OAP-189 in subjects with type 2 diabetes who are taking metformin for their diabetes.
Timeline
- Start
- 2009-09-02
- Primary completion
- 2011-07-25
- Completion
- 2011-07-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | OAP-189 | Unknown | 0.2 mg | — |
| Comparator | OAP-189 | Unknown | 0.4 mg | — |
| Comparator | OAP-189 | Unknown | 1.2 mg | — |
| Comparator | OAP-189 | Unknown | 1.6 mg | — |